Tag: antibody-drug conjugate
Polatuzumab offers new hope for DLBCL patients on World Lymphoma Day
The first FDA-approved DLBCL treatment in nearly 20 years, Polatuzumab shows results in reducing relapse and disease progression
IISER-Bhopal scientists develop new method to synthesize bio-conjugates
The researchers at Indian Institute of Science Education and Research (IISER), Bhopal, have now demonstrated that it was possible to synthesize an effective conjugate with lysine without much of a problem....................